# WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)

> **NCT02741817** · PHASE4 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 20 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT02741817
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-26
- **Primary completion:** 2017-04-07
- **Final completion:** 2017-04-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02741817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02741817, "WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02741817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*